Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

Efficacy, safety, and pharmacokinetics of vericiguat in pediatric participants with heart failure due to left ventricular systolic dysfunction

VALOR

Condition: Cardiology
Phase: II/III

What is the goal of the study?

Phase 2/3 adaptive randomized, placebo-controlled, parallel-group, multisite, double-blind study of vericiguat in pediatric participants with HF due to LV systolic dysfunction consistent with dilated cardiomyopathy and NT-proBNP level between 500 and 6000 pg/mL within 30 days before randomization.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Yuk Law
Study Team Member: Annabeth Evans, Annabeth.Evans@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.